34 related articles for article (PubMed ID: 30480917)
1. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.
Hunter DJ; Kraft P; Jacobs KB; Cox DG; Yeager M; Hankinson SE; Wacholder S; Wang Z; Welch R; Hutchinson A; Wang J; Yu K; Chatterjee N; Orr N; Willett WC; Colditz GA; Ziegler RG; Berg CD; Buys SS; McCarty CA; Feigelson HS; Calle EE; Thun MJ; Hayes RB; Tucker M; Gerhard DS; Fraumeni JF; Hoover RN; Thomas G; Chanock SJ
Nat Genet; 2007 Jul; 39(7):870-4. PubMed ID: 17529973
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of breast cancer susceptibility loci in Chinese women.
Long J; Shu XO; Cai Q; Gao YT; Zheng Y; Li G; Li C; Gu K; Wen W; Xiang YB; Lu W; Zheng W
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2357-65. PubMed ID: 20699374
[TBL] [Abstract][Full Text] [Related]
3. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Meyer KB; O'Reilly M; Michailidou K; Carlebur S; Edwards SL; French JD; Prathalingham R; Dennis J; Bolla MK; Wang Q; de Santiago I; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Schmidt MK; Broeks A; Van 't Veer LJ; Hogervorst FB; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Lux MP; Ekici AB; Beckmann MW; Peto J; Dos Santos Silva I; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Truong T; Laurent-Puig P; Menegaux F; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Milne RL; Zamora MP; Arias JI; Benitez J; Neuhausen S; Anton-Culver H; Ziogas A; Dur CC; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Schmutzler RK; Engel C; Ditsch N; Brauch H; Brüning T; Ko YD; ; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Matsuo K; Ito H; Iwata H; Yatabe Y; Dörk T; Helbig S; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Chenevix-Trench G; ; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Lambrechts D; Thienpont B; Christiaens MR; Smeets A; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Radice P; Peterlongo P; Bonanni B; Bernard L; Couch FJ; Olson JE; Wang X; Purrington K; Giles GG; Severi G; Baglietto L; McLean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; Phuah SY; Kristensen V; Grenaker Alnæs G; Børresen-Dale AL; Zheng W; Deming-Halverson S; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve CM; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Darabi H; Eriksson K; Hooning MJ; Martens JW; van den Ouweland AM; van Deurzen CH; Hall P; Li J; Liu J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cox A; Reed MW; Blot W; Signorello LB; Cai Q; Pharoah PD; Ghoussaini M; Harrington P; Tyrer J; Kang D; Choi JY; Park SK; Noh DY; Hartman M; Hui M; Lim WY; Buhari SA; Hamann U; Försti A; Rüdiger T; Ulmer HU; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Vachon C; Slager S; Fostira F; Pilarski R; Shen CY; Hsiung CN; Wu PE; Hou MF; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Ponder BA; Dunning AM; Easton DF
Am J Hum Genet; 2013 Dec; 93(6):1046-60. PubMed ID: 24290378
[TBL] [Abstract][Full Text] [Related]
4. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.
Ghoussaini M; French JD; Michailidou K; Nord S; Beesley J; Canisus S; Hillman KM; Kaufmann S; Sivakumaran H; Moradi Marjaneh M; Lee JS; Dennis J; Bolla MK; Wang Q; Dicks E; Milne RL; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Alonso MR; Pita G; Neuhausen SL; Anton-Culver H; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Tessier DC; Vincent D; Nevanlinna H; Khan S; Matsuo K; Ito H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; ; Wu AH; Van Den Berg D; Lambrechts D; Floris G; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Hallberg E; Giles GG; Haiman CA; Le Marchand L; Goldberg MS; Teo SH; Yip CH; Borresen-Dale AL; ; Zheng W; Cai Q; Winqvist R; Pylkäs K; Andrulis IL; Devilee P; Tollenaar RA; García-Closas M; Figueroa J; Hall P; Czene K; Brand JS; Darabi H; Eriksson M; Hooning MJ; Koppert LB; Li J; Shu XO; Zheng Y; Cox A; Cross SS; Shah M; Rhenius V; Choi JY; Kang D; Hartman M; Chia KS; Kabisch M; Torres D; Luccarini C; Conroy DM; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Olswold C; Slager S; Shen CY; Hou MF; Swerdlow A; Schoemaker MJ; Simard J; Pharoah PD; Kristensen V; Chenevix-Trench G; Easton DF; Dunning AM; Edwards SL
Am J Hum Genet; 2016 Oct; 99(4):903-911. PubMed ID: 27640304
[TBL] [Abstract][Full Text] [Related]
5. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
Agarwal D; Pineda S; Michailidou K; Herranz J; Pita G; Moreno LT; Alonso MR; Dennis J; Wang Q; Bolla MK; Meyer KB; Menéndez-Rodríguez P; Hardisson D; Mendiola M; González-Neira A; Lindblom A; Margolin S; Swerdlow A; Ashworth A; Orr N; Jones M; Matsuo K; Ito H; Iwata H; Kondo N; ; ; Hartman M; Hui M; Lim WY; Iau PT; Sawyer E; Tomlinson I; Kerin M; Miller N; Kang D; Choi J-; Park SK; Noh D-; Hopper JL; Schmidt DF; Makalic E; Southey MC; Teo SH; Yip CH; Sivanandan K; Tay W-; Brauch H; Brüning T; Hamann U; ; Dunning AM; Shah M; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Schmidt MK; Broeks A; Rosenberg EH; van't Veer LJ; Fasching PA; Renner SP; Ekici AB; Beckmann MW; Shen C-; Hsiung C-; Yu J-; Hou M-; Blot W; Cai Q; Wu AH; Tseng C-; Van Den Berg D; Stram DO; Cox A; Brock IW; Reed MW; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Zheng W; Deming-Halverson S; Shrubsole MJ; Long J; Shu X-; Lu W; Gao Y-; Zhang B; Radice P; Peterlongo P; Manoukian S; Mariette F; Sangrajrang S; McKay J; Couch FJ; Toland AE; ; Yannoukakos D; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Marme F; Burwinkel B; Guénel P; Truong T; Sanchez M; Mulot C; Bojesen SE; Nordestgaard BG; Flyer H; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Mannermaa A; Kataja V; Kosma V-; Hartikainen JM; Lambrechts D; Yesilyurt BT; Floris G; Leunen K; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Wang X; Olson JE; Vachon C; Purrington K; Giles GG; Severi G; Baglietto L; Haiman CA; Henderson BE; Schumacher F; Marchand LL; Simard J; Dumont M; Goldberg MS; Labréche F; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Chanock SJ; Lissowska J; Figueroa JD; Czene K; Eriksson M; Humphreys K; Darabi H; Hooning MJ; Kriege M; Collée JM; Tilanus-Linthorst M; Li J; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Bogdanova N; Dörk T; Hall P; Chenevix-Trench G; Easton DF; Pharroah PD; Arias-Perez JI; Zamora P; Benítez J; Milne RL
Br J Cancer; 2014 Feb; 110(4):1088-100. PubMed ID: 24548884
[TBL] [Abstract][Full Text] [Related]
6. FGFR2 genetic variants in women with breast cancer.
Dix-Peek T; Dickens C; Augustine TN; Phakathi BP; Van Den Berg EJ; Joffe M; Ayeni OA; Cubasch H; Nietz S; Mathew CG; Hayat M; Neugut AI; Jacobson JS; Ruff P; Duarte RAB
Mol Med Rep; 2023 Dec; 28(6):. PubMed ID: 37830168
[TBL] [Abstract][Full Text] [Related]
7. Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study.
Park HL; Ziogas A; Chang J; Desai B; Bessonova L; Garner C; Lee E; Neuhausen SL; Wang SS; Ma H; Clague J; Reynolds P; Lacey JV; Bernstein L; Anton-Culver H
BMC Cancer; 2016 Jan; 16():14. PubMed ID: 26758508
[TBL] [Abstract][Full Text] [Related]
8. Association Between Polymorphisms in DNA Damage Repair Pathway Genes and Female Breast Cancer Risk.
Wang Y; Sun Y; Tan M; Lin X; Tai P; Huang X; Jin Q; Yuan D; Xu T; He B
DNA Cell Biol; 2024 May; 43(5):219-231. PubMed ID: 38634815
[TBL] [Abstract][Full Text] [Related]
9. 11q13 is a susceptibility locus for hormone receptor positive breast cancer.
Lambrechts D; Truong T; Justenhoven C; Humphreys MK; Wang J; Hopper JL; Dite GS; Apicella C; Southey MC; Schmidt MK; Broeks A; Cornelissen S; van Hien R; Sawyer E; Tomlinson I; Kerin M; Miller N; Milne RL; Zamora MP; Pérez JI; Benítez J; Hamann U; Ko YD; Brüning T; ; Chang-Claude J; Eilber U; Hein R; Nickels S; Flesch-Janys D; Wang-Gohrke S; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Chenevix-Trench G; Beesley J; Chen X; ; ; Menegaux F; Cordina-Duverger E; Shen CY; Yu JC; Wu PE; Hou MF; Andrulis IL; Selander T; Glendon G; Mulligan AM; Anton-Culver H; Ziogas A; Muir KR; Lophatananon A; Rattanamongkongul S; Puttawibul P; Jones M; Orr N; Ashworth A; Swerdlow A; Severi G; Baglietto L; Giles G; Southey M; Marmé F; Schneeweiss A; Sohn C; Burwinkel B; Yesilyurt BT; Neven P; Paridaens R; Wildiers H; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Schott S; Bartram CR; Schmutzler RK; Cox A; Brock IW; Elliott G; Cross SS; Fasching PA; Schulz-Wendtland R; Ekici AB; Beckmann MW; Fletcher O; Johnson N; Silva Idos S; Peto J; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Dörk T; Schürmann P; Bremer M; Hillemanns P; Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Khusnutdinova E; Bermisheva M; Prokofieva D; Gancev S; Jakubowska A; Lubinski J; Jaworska K; Durda K; Nordestgaard BG; Bojesen SE; Lanng C; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Radice P; Peterlongo P; Manoukian S; Bernard L; Couch FJ; Olson JE; Wang X; Fredericksen Z; Alnaes GG; Kristensen V; Børresen-Dale AL; Devilee P; Tollenaar RA; Seynaeve CM; Hooning MJ; García-Closas M; Chanock SJ; Lissowska J; Sherman ME; Hall P; Liu J; Czene K; Kang D; Yoo KY; Noh DY; Lindblom A; Margolin S; Dunning AM; Pharoah PD; Easton DF; Guénel P; Brauch H
Hum Mutat; 2012 Jul; 33(7):1123-32. PubMed ID: 22461340
[TBL] [Abstract][Full Text] [Related]
10. Genome-Wide Meta-analysis of Gene-Environmental Interaction for Insulin Resistance Phenotypes and Breast Cancer Risk in Postmenopausal Women.
Jung SY; Mancuso N; Yu H; Papp J; Sobel E; Zhang ZF
Cancer Prev Res (Phila); 2019 Jan; 12(1):31-42. PubMed ID: 30327367
[TBL] [Abstract][Full Text] [Related]
11. The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling.
Hoffman AE; Zheng T; Yi CH; Stevens RG; Ba Y; Zhang Y; Leaderer D; Holford T; Hansen J; Zhu Y
Cancer Prev Res (Phila); 2010 Apr; 3(4):539-48. PubMed ID: 20233903
[TBL] [Abstract][Full Text] [Related]
12. Association of Genome-Wide Association Study (GWAS) Identified SNPs and Risk of Breast Cancer in an Indian Population.
Nagrani R; Mhatre S; Rajaraman P; Chatterjee N; Akbari MR; Boffetta P; Brennan P; Badwe R; Gupta S; Dikshit R
Sci Rep; 2017 Jan; 7():40963. PubMed ID: 28098224
[TBL] [Abstract][Full Text] [Related]
13. Progesterone Receptor Gene Polymorphisms and Breast Cancer Risk.
Vang A; Salem K; Fowler AM
Endocrinology; 2023 Feb; 164(4):. PubMed ID: 36702635
[TBL] [Abstract][Full Text] [Related]
14. Master regulators of FGFR2 signalling and breast cancer risk.
Fletcher MN; Castro MA; Wang X; de Santiago I; O'Reilly M; Chin SF; Rueda OM; Caldas C; Ponder BA; Markowetz F; Meyer KB
Nat Commun; 2013; 4():2464. PubMed ID: 24043118
[TBL] [Abstract][Full Text] [Related]
15. A sequential methodology for the rapid identification and characterization of breast cancer-associated functional SNPs.
Zhao Y; Wu D; Jiang D; Zhang X; Wu T; Cui J; Qian M; Zhao J; Oesterreich S; Sun W; Finkel T; Li G
Nat Commun; 2020 Jul; 11(1):3340. PubMed ID: 32620845
[TBL] [Abstract][Full Text] [Related]
16. Association of
Glebauskiene B; Vilkeviciute A; Liutkeviciene R; Jakstiene S; Kriauciuniene L; Zemaitiene R; Zaliuniene D
Oncol Lett; 2017 May; 13(5):3087-3099. PubMed ID: 28521414
[TBL] [Abstract][Full Text] [Related]
17. Supervariants identification for breast cancer.
Hu J; Li T; Wang S; Zhang H
Genet Epidemiol; 2020 Nov; 44(8):934-947. PubMed ID: 32808324
[TBL] [Abstract][Full Text] [Related]
18. The Contribution of Race to Breast Tumor Microenvironment Composition and Disease Progression.
Kim G; Pastoriza JM; Condeelis JS; Sparano JA; Filippou PS; Karagiannis GS; Oktay MH
Front Oncol; 2020; 10():1022. PubMed ID: 32714862
[TBL] [Abstract][Full Text] [Related]
19. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
